Invesco China Small Cap ETF (HAO) News
Filter HAO News Items
HAO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest HAO News From Around the Web
Below are the latest news stories about HAOXI HEALTH TECHNOLOGY LTD that investors may wish to consider to help them evaluate HAO as an investment opportunity.
Haoxi Health Technology Limited Awarded a RMB30 Milllion Framework Contract to Provide Digital Advertising Services for Tengyuan Media Advertising Co., Ltd.BEIJING, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced the Company’s wholly owned subsidiary Beijing Haoxi Digital Technology Co., Ltd. (“Beijing Haoxi”) was awarded a Recharge Service Framework Contract (the “Contract”) to provide comprehensive digital advertising services with a budget of RMB30 million for Tengyuan Media Advertising Co., Ltd. (“Tengyuan") and its |
Haoxi Health Technology Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyBEIJING, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that the Company received a letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) on October 31, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued l |
Haoxi Health Technology Limited Reports Financial Results for Fiscal Year Ended June 30, 2024BEIJING, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today reported its financial results for the fiscal year ended June 30, 2024. Financial Highlights for Fiscal 2024 Net revenue for the fiscal year ended June 30, 2024 grew by 72% to $48.52 million, up from $28.23 million in 2023.Gross profit increased by 33% to $2.75 million for the fiscal year ended June 30, 2024 from $2.06 m |
Haoxi Health Technology sees FY24 revenue $48.52M vs. $28.23M last yearHAO projects revenue growth during FY24, which it attributes to the Company’s strategic development in online advertising solutions, particularly through short video formats and news feed ads. The Company’s proprietary data analysis software, Bidding Compass, enables it to optimize ad placements, which it believes has driven growth in both revenue and profit for FY24. Gross Profit: Approximately $2.75 million for FY24, reflecting a 33.4% increase from $2.06 million in FY23. Net Income: Approxima |
Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue GrowthBEIJING, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced preliminary unaudited financial results for the fiscal year ended June 30, 2024 (“FY24”). HAO projects revenue growth during FY24, which it attributes to the Company’s strategic development in online advertising solutions, particularly through short video formats and news feed ads. The Company’s proprietary dat |
Haoxi Health Technology Limited and Global Mofy AI Ltd Announce Strategic Partnership to Innovate AI Marketing SolutionsBEIJING, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced a strategic partnership with an AI platform, Gauss Intelligence (Beijing) Technology Co., Ltd., a subsidiary of Global Mofy AI Ltd (Nasdaq: GMM). This collaboration aims to leverage the advanced capabilities of Gausspeed, a cutting-edge generative AI platform, alongside HAO’s extensive application scenarios to |
Haoxi Health Technology Limited Announces the Closing of a $12 Million Underwritten Follow-on Public OfferingBEIJING, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it closed its previously announced underwritten follow-on offering of 4,000,000 units (each a “Unit,” and collectively, the “Units”) at a public offering price of $3.00 per Unit (the “Offering”). Each Unit consists of (i) one share of Class A Ordinary Share, par value $0.0001 per share (the “Class A Ordin |
Haoxi Health Technology Limited Announces Pricing of a $12 Million Underwritten Follow-on Public OfferingBEIJING, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced the pricing of its underwritten follow-on public offering (the "Offering") of 4,000,000 units (each a “Unit,” and collectively, the “Units”) at an offering price of $3.00 per Unit (the “Public Offering Price”) for total gross proceeds of $12,000,000, before deducting underwriting discounts and other offering e |
Is Haoxi Health Technology Limited (NASDAQ:HAO) A High Quality Stock To Own?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is... |
Haoxi Health Technology Limited Facilitates International Humanitarian Aid Efforts Amid Global ChallengesBEIJING, June 10, 2024--HAO has established a dedicated service team, collaborating closely with medical aid organizations to assess frontline medical supply requirements. |